Cargando…
The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Approximately 18.1 × 10(6) new cases of cancer were recorded globally in 2018, out of which 9.6 million died. It is known that people who have Inflammatory Bowel Disease (IBD) turn to be prone to increased risks of developing colorectal cancer (CRC), which has global incident and mortality rates of...
Autores principales: | Ocansey, Dickson Kofi Wiredu, Qiu, Wei, Wang, Jingyan, Yan, Yongmin, Qian, Hui, Zhang, Xu, Xu, Wenrong, Mao, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104387/ https://www.ncbi.nlm.nih.gov/pubmed/32256612 http://dx.doi.org/10.1155/2020/7819824 |
Ejemplares similares
-
Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2019) -
Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020) -
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022) -
The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu, Xinwei, et al.
Publicado: (2021) -
The Effects of Mesenchymal Stem Cell on Colorectal Cancer
por: Yuan, Jintao, et al.
Publicado: (2021)